Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

A mitochondrial power play in lymphoma.

Deberardinis RJ.

Cancer Cell. 2012 Oct 16;22(4):423-4. doi: 10.1016/j.ccr.2012.09.023.

2.

Differential contribution of the mitochondrial translation pathway to the survival of diffuse large B-cell lymphoma subsets.

Norberg E, Lako A, Chen PH, Stanley IA, Zhou F, Ficarro SB, Chapuy B, Chen L, Rodig S, Shin D, Choi DW, Lee S, Shipp MA, Marto JA, Danial NN.

Cell Death Differ. 2016 Oct 21. doi: 10.1038/cdd.2016.116. [Epub ahead of print]

PMID:
27768122
3.

S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase.

Chiarle R, Fan Y, Piva R, Boggino H, Skolnik J, Novero D, Palestro G, De Wolf-Peeters C, Chilosi M, Pagano M, Inghirami G.

Am J Pathol. 2002 Apr;160(4):1457-66.

4.

Power cut: inhibiting mitochondrial translation to target leukemia.

Järås M, Ebert BL.

Cancer Cell. 2011 Nov 15;20(5):555-6. doi: 10.1016/j.ccr.2011.10.028.

5.
6.

Leukemia and lymphoma in ataxia telangiectasia.

Taylor AM, Metcalfe JA, Thick J, Mak YF.

Blood. 1996 Jan 15;87(2):423-38. Review.

7.

The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas.

D'Andrea A, Gritti I, Nicoli P, Giorgio M, Doni M, Conti A, Bianchi V, Casoli L, Sabò A, Mironov A, Beznoussenko GV, Amati B.

Oncotarget. 2016 Aug 31. doi: 10.18632/oncotarget.11719. [Epub ahead of print]

8.

[Molecular abnormalities in lymphomas].

Delsol G.

Bull Cancer. 2010 Nov;97(11):1347-64. doi: 10.1684/bdc.2010.1214. Review. French.

9.

ID3 mutations are recurrent events in double-hit B-cell lymphomas.

Gebauer N, Bernard V, Feller AC, Merz H.

Anticancer Res. 2013 Nov;33(11):4771-8.

PMID:
24222112
10.

Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma.

Aukema SM, Kreuz M, Kohler CW, Rosolowski M, Hasenclever D, Hummel M, Küppers R, Lenze D, Ott G, Pott C, Richter J, Rosenwald A, Szczepanowski M, Schwaenen C, Stein H, Trautmann H, Wessendorf S, Trümper L, Loeffler M, Spang R, Kluin PM, Klapper W, Siebert R; Molecular Mechanisms in Malignant Lymphomas Network Project..

Haematologica. 2014 Apr;99(4):726-35. doi: 10.3324/haematol.2013.091827.

11.

Mitochondrial Dysfunction and Disturbed Coherence: Gate to Cancer.

Pokorný J, Pokorný J, Foletti A, Kobilková J, Vrba J, Vrba J.

Pharmaceuticals (Basel). 2015 Sep 30;8(4):675-95. doi: 10.3390/ph8040675. Review.

12.

Management of paediatric lymphoma.

Philip T, Bergeron C, Frappaz D.

Baillieres Clin Haematol. 1996 Dec;9(4):769-97. Review.

PMID:
9138617
13.

In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas.

Mason KD, Vandenberg CJ, Scott CL, Wei AH, Cory S, Huang DC, Roberts AW.

Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17961-6. doi: 10.1073/pnas.0809957105.

14.

Myeloid, B and T lymphoid and mixed lineage thymic lymphomas in the irradiated mouse.

Boulton E, Cleary H, Plumb M.

Carcinogenesis. 2002 Jun;23(6):1079-85.

15.

Defective expression of MHC class I antigens is frequent in B-cell lymphomas of high-grade malignancy.

Möller P, Herrmann B, Moldenhauer G, Momburg F.

Int J Cancer. 1987 Jul 15;40(1):32-9.

PMID:
3298077
16.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Review.

PMID:
12042984
17.

Mitochondrial biogenesis: pharmacological approaches.

Valero T.

Curr Pharm Des. 2014;20(35):5507-9.

PMID:
24606795
18.

Pharmacological targeting of valosin containing protein (VCP) induces DNA damage and selectively kills canine lymphoma cells.

Nadeau MÈ, Rico C, Tsoi M, Vivancos M, Filimon S, Paquet M, Boerboom D.

BMC Cancer. 2015 Jun 24;15:479. doi: 10.1186/s12885-015-1489-1.

19.

On the aetiology of Hodgkin lymphoma.

Hjalgrim H.

Dan Med J. 2012 Jul;59(7):B4485. Review.

PMID:
22759852
20.

Diffuse aggressive lymphoma.

Fisher RI, Miller TP, O'Connor OA.

Hematology Am Soc Hematol Educ Program. 2004:221-36. Review.

PMID:
15561685
Items per page

Supplemental Content

Support Center